We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current TN8 market cap is 182.07B. The company's latest EPS is USD 16.7921 and P/E is 30.83.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 32.22B | 39.21B | 44.92B | 42.86B | 42.88B |
| Operating Income | 7.79B | 10.03B | 8.39B | 6.86B | 7.34B |
| Net Income | 6.38B | 7.73B | 6.95B | 6B | 6.34B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 69.05B | 95.12B | 97.15B | 98.73B | 97.32B |
| Total Liabilities | 34.55B | 54.15B | 53.01B | 51.88B | 47.65B |
| Total Equity | 34.51B | 40.86B | 44.03B | 46.72B | 49.55B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 8.29B | 9.31B | 9.15B | 8.41B | 8.67B |
| Investing | -1.51B | -21.93B | -2.16B | -5.14B | -5.84B |
| Financing | 959M | 6.58B | -2.81B | -3.62B | -6.79B |
| Market Cap | 182.07B |
| Price to Earnings Ratio | 30.83 |
| Price to Sales Ratio | 4.56 |
| Price to Cash Ratio | 48.72 |
| Price to Book Ratio | 3.93 |
| Dividend Yield | 0.39% |
| Shares Outstanding | 377.26M |
| Average Volume (1 week) | 583 |
| Average Volume (1 Month) | 875 |
| 52 Week Change | -10.00% |
| 52 Week High | 587.30 |
| 52 Week Low | 466.35 |
| Spread (Intraday) | 3.1 (0.64%) |
| Company Name | Thermo Fisher Scientific Inc |
| Address |
108 lakeland ave dover, delaware 19901 |
| Website | https://www.thermofisher.com |
| Industry | meas & controlling dev, nec (3829) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
